Modified DNA Methyltransferase for CC Dinucleotide Recognition

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing DNA methyltransferases (MTases) have recognition sequences that overlap with CG dinucleotide sequences, leading to interference with endogenous methylation in mammalian cells, and their longer recognition sequences limit fine epigenetic mapping resolution.

Innovation Solution

A novel DNA methyltransferase (MTase) is developed that specifically recognizes and methylates CC dinucleotide sequences, avoiding overlap with CG dinucleotides and utilizing a shorter recognition sequence for improved epigenetic mapping resolution.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing DNA methyltransferases are used, then methylation can be introduced, but the recognition sequences overlap with CG dinucleotide sequences causing interference with endogenous methylation

Engineering Contradiction:
Improvespecificity of methylationVSAvoidinterference with endogenous methylation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the recognition sequence specificity of DNA methyltransferase to target CC dinucleotides instead of CG dinucleotides. This local change in substrate specificity allows the enzyme to perform methylation without interfering with endogenous CG methylation processes, resolving the contradiction between introducing methylation and avoiding interference with endogenous methylation.

Inventive Principle:
Principle #3Local quality

2Measurement precision

If existing DNA methyltransferases with longer recognition sequences are used, then stable enzyme-DNA binding is achieved, but the resolution for fine epigenetic mapping is limited

Engineering Contradiction:
Improveepigenetic mapping resolutionVSAvoidrecognition sequence length
Core Design Contradiction:
Measurement precisionVSLength of stationary object

Solution Approach 1:

The patent changes the recognition sequence parameter from longer sequences (e.g., 4-6 bases) to a shorter CC dinucleotide sequence (2 bases). This parameter change in recognition sequence length enables higher resolution epigenetic mapping while the enzyme maintains sufficient binding stability through optimized catalytic activity on the shorter sequence.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The novel MTase enables distinguishable methylation from endogenous methylation, allowing for simultaneous profiling of endogenous methylation and other epigenomes with enhanced resolution, facilitating advanced epigenome analysis.

Implementation Method 1

DNA methyltransferases (MTases) are enzymes inducing methylation, which is one of the representative epigenetic modifications of DNA

Methodology Applied
Scientific EffectMethylation:

Implementation Method 2

a protein modified to delete some amino acid residues including the N-terminal end of DNA methyltransferase M.CviQIX or M.CviPII and thereby acquire the ability to specifically recognize a CC dinucleotide sequence and 5-methylate the 5'-position cytosine residue in the sequence

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentEP4534656A1DNA methyltransferase
Publication Date: 2025.04.09 THE JAPAN SCI & TECH AGENCY
  • EP4534656A1 patent drawingFigure 1
  • EP4534656A1 patent drawingFigure 2A~2C
  • EP4534656A1 patent drawingFigure 3A~3E

AI summary

The present invention provides a DNA methyltransferase that is capable of recognizing and methylating a short context other than but equivalent to a CG dinucleotide sequence where endogenous methylation occurs, etc. The present invention relates to a protein modified to delete some amino acid residues including the N-terminal end of DNA methyltransferase M.CviQIX or M.CviPII and thereby acquire the ability to specifically recognize a CC dinucleotide sequence and 5-methylate the 5'-position cytosine residue in the sequence, etc.